Take­da se­lects for­mer CRISPR Ther­a­peu­tics CMO to lead on­col­o­gy unit; Emile Nuwaysir out at En­so­ma

→ A spokesper­son for Take­da tells Peer Re­view that PK Mor­row suc­ceed­ed Chris Arendt as head of on­col­o­gy on Jan. 29. A few weeks ago …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.